EUVIMEDEUVIMED entdecken
Crossref

GESTATIONAL RHINITIS AND THE DIAGNOSIS AND SAFETY OF NASAL TREATMENT

Hewellynn de Azeredo Gomes, Pedro Henrique Moysés Pereira, Mauricio Martins Montazolli Filho, Victoria de Vargas Silva, Felipe Nicolau Oliveira da Costa, Ana Claudia Recchia Barbosa, Ricardo Massaiti Koshiba do Amaral, Leonardo Todeschini Justus, Carlos Eduardo Colombeki Saldanha, Leonardo Schaucoski Cizeski

LUMEN ET VIRTUS · 11.11.2026 · 17 (66) · e15360

DOI: 10.56238/levv17n66-053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LUMEN ET VIRTUS, online erschienen am 11.11.2026. Verfasst von Hewellynn de Azeredo Gomes und 9 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational rhinitis is a clinically defined condition characterized by persistent nasal obstruction arising during pregnancy without an infectious or established allergic explanation and resolving shortly after childbirth. Its importance extends beyond nasal discomfort because congestion can disturb sleep, impair daily functioning, and encourage prolonged use of topical decongestants. This narrative review examines diagnostic criteria, mechanisms, differential diagnosis, treatment efficacy, and the interpretation of maternal and fetal safety evidence. Targeted searches of PubMed and professional guidance identified epidemiological studies, physiological investigations, controlled treatment trials, pregnancy exposure cohorts, and clinical recommendations. Evidence was synthesized descriptively without a new meta-analysis. A Swedish antenatal study reported a cumulative incidence of 22%, although estimates vary substantially with case definition, population, and observation period. Hormonal and vascular mechanisms are plausible, but available studies do not support a diagnostic hormone assay or establish one consistent causal pathway. Treatment should begin with explanation, saline, avoidance of irritants, appropriate positioning, and optional mechanical nasal dilation. Intranasal corticosteroids may be appropriate for coexisting allergic or inflammatory disease, but the small placebo-controlled fluticasone trial in isolated gestational rhinitis did not demonstrate symptomatic benefit. Observational pregnancy data are broadly reassuring for several nasal corticosteroids and selected antihistamines, while remaining insufficient to exclude small increases in rare outcomes. Decongestants require particular caution because systemic exposure, uncertain reproductive safety, and rebound congestion complicate repeated use. Persistent unilateral obstruction, bleeding, facial or orbital symptoms, and suspected sleep apnea require targeted evaluation. The safest strategy combines a specific diagnosis, treatment matched to the underlying phenotype, restrained medication exposure, and reassessment after delivery.

Zitieren

APA

Gomes, H. D. A., Pereira, P. H. M., Filho, M. M. M., Silva, V. D. V., Costa, F. N. O. D., Barbosa, A. C. R., Amaral, R. M. K. D., Justus, L. T., Saldanha, C. E. C., & Cizeski, L. S. (2026). GESTATIONAL RHINITIS AND THE DIAGNOSIS AND SAFETY OF NASAL TREATMENT. LUMEN ET VIRTUS, 17(66), e15360. https://doi.org/10.56238/levv17n66-053

Vancouver

Gomes HDA, Pereira PHM, Filho MMM, Silva VDV, Costa FNOD, Barbosa ACR, et al. GESTATIONAL RHINITIS AND THE DIAGNOSIS AND SAFETY OF NASAL TREATMENT. LUMEN ET VIRTUS. 2026;17(66):e15360. doi:10.56238/levv17n66-053

BibTeX
@article{Gomes2026,
  author = {Gomes, Hewellynn de Azeredo and Pereira, Pedro Henrique Moysés and Filho, Mauricio Martins Montazolli and Silva, Victoria de Vargas and Costa, Felipe Nicolau Oliveira da and Barbosa, Ana Claudia Recchia and Amaral, Ricardo Massaiti Koshiba do and Justus, Leonardo Todeschini and Saldanha, Carlos Eduardo Colombeki and Cizeski, Leonardo Schaucoski},
  title = {GESTATIONAL RHINITIS AND THE DIAGNOSIS AND SAFETY OF NASAL TREATMENT},
  journal = {LUMEN ET VIRTUS},
  year = {2026},
  volume = {17},
  number = {66},
  pages = {e15360},
  doi = {10.56238/levv17n66-053}
}
Kostenlos starten →